FAPI-PET for Tumor Detection

Launched by UNIVERSITY HOSPITAL, ESSEN · Sep 24, 2020

Keywords

ClinConnect Summary

This clinical trial, called FAPI-PET for Tumor Detection, is studying a special type of imaging called FAPI-PET, which helps doctors find and assess tumors in patients who have or may have cancer. The trial aims to understand how well this imaging method works compared to other tests, how accurately it identifies tumors, and how it can help doctors make better decisions about patient care. The study is currently looking for participants aged 18 and older who are scheduled to receive FAPI-PET imaging for staging or restaging of their cancer.

If you decide to participate, you will undergo the FAPI-PET scan as part of your routine care. This study is important because it could improve the way tumors are detected and monitored, ultimately helping to tailor treatments for patients. However, please note that individuals who cannot give consent, lie flat, or have certain critical health conditions may not be eligible to join, as well as pregnant or breastfeeding women. Your involvement could contribute to valuable research in the fight against cancer.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. FAPI-PET scheduled for staging or restaging as part of clinical routine for proven or suspected malignancy
• • 2. Age ≥ 18 years.
• Exclusion Criteria:
• • 1. Patient cannot give consent for the study
• • 2. Patient can not lie flat or tolerate FAPI PET imaging
• • 3. Unwillingness or inability to comply with study and follow-up procedures
• • 4. Condition of patient which is critical to participate in this study in the discretion of the investigators
• • 5. Pregnant, lactating, or breast feeding women.